Skip to main content
Premium Trial:

Request an Annual Quote

CeMines Estonian Subsidiary Co-Founds Cancer Diagnostics and Therapeutics Firm

NEW YORK, Jan. 11 (GenomeWeb News) - CeMines Estonia OU, a subsidiary of CeMines International, has co-founded VTAK, a privately held company focused on researching and commercializing cancer diagnostics and therapeutics, CeMines said yesterday.


VTAK was founded in conjunction with the Estonian government, as well as several academic institutions and companies including Tallinn Technical University; Helsinki Yliopiston Saatio; Regional Hospital of North Estonia; ProSyntest AS; Kevelt AS; CeleCure AS; Trial Form Support AB; and InBio OU.


Golden, Colo.-based CeMines is the only US-based company participating in VTAK, the company said. CeMines created the CeMines International operating division and its Estonian subsidiary in December.